1
|
Hsu NS, Tehei M, Hossain MS, Rosenfeld A, Shiddiky MJA, Sluyter R, Dou SX, Yamauchi Y, Konstantinov K. Oxi-Redox Selective Breast Cancer Treatment: An In Vitro Study of Theranostic In-Based Oxide Nanoparticles for Controlled Generation or Prevention of Oxidative Stress. ACS Appl Mater Interfaces 2021; 13:2204-2217. [PMID: 33399455 DOI: 10.1021/acsami.0c17326] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
In this article, we demonstrate that specifically engineered oxide nanoparticles (NPs) have the potential to act as theranostic materials that are able to generate or prevent oxidative stress through their oxi-redox activity in various types of malignant and nonmalignant cells. The oxi-redox activity is related to the type and presence of surface defects, which is modified with appropriate synthesis conditions. In the present work, we used MDA-MB-231 and MCF-7 human breast cancer cells and nonmalignant MCF-10A human breast cells to demonstrate how controlled oxidative stress mediated by specifically nanoengineered indium tin oxide (ITO) NPs can selectively induce cell death in the cancer cells while reducing the oxidative stress in the normal cells and supporting their proliferation. The ITO NPs are also promising nanotheranostic materials for cancer therapy and contrast agents because of their multimodal imaging capabilities. We demonstrate that the synthesized ITO NPs can selectively increase the generation of reactive oxygen species (ROS) in both breast tumor cell lines, resulting in activation of apoptosis, and can also greatly suppress the cellular proliferation in both types of tumor cells. In contrast, the ITO NPs exhibit ROS scavenging-like behavior, significantly decreasing the ROS levels in MCF-10A cells exposed to the additional ROS, hydrogen peroxide (H2O2), so that they protect the proliferation of nonmalignant MCF-10A cells from ROS damage. In addition, fluorescent microscopy images revealed that the ITO NPs emit strong fluorescence that could be used to reveal their location. Moreover, computed tomography imaging demonstrated that the ITO NPs exhibited a comparable capability toward anatomical contrast enhancement. These results suggest that the synthesized ITO NPs have the potential to be a novel selective therapeutic agent with a multimodal imaging property for anticancer treatment.
Collapse
Affiliation(s)
- Nai-Sheng Hsu
- Institute for Superconducting and Electronic Materials, Australian Institute for Innovative Materials, University of Wollongong, 2500 North Wollongong, New South Wales, Australia
- Illawarra Health and Medical Research Institute, University of Wollongong, 2500 Wollongong, New South Wales, Australia
| | - Moeava Tehei
- Illawarra Health and Medical Research Institute, University of Wollongong, 2500 Wollongong, New South Wales, Australia
- Centre for Medical and Radiation Physics, Faculty of Engineering and Information Science, University of Wollongong, 2500 Wollongong, New South Wales, Australia
| | - Md Shahriar Hossain
- Australian Institute for Bioengineering and Nanotechnology, School of Mechanical and Mining Engineering, Faculty of Engineering, Architecture and Information Technology, The University of Queensland, 4072 Brisbane, Queensland, Australia
| | - Anatoly Rosenfeld
- Illawarra Health and Medical Research Institute, University of Wollongong, 2500 Wollongong, New South Wales, Australia
- Centre for Medical and Radiation Physics, Faculty of Engineering and Information Science, University of Wollongong, 2500 Wollongong, New South Wales, Australia
| | - Muhammad J A Shiddiky
- School of Environment and Science (ESC) & Queensland Micro- and Nanotechnology Centre (QMNC), Griffith University, Nathan Campus, Nathan, Queensland 4111, Australia
| | - Ronald Sluyter
- Illawarra Health and Medical Research Institute, University of Wollongong, 2500 Wollongong, New South Wales, Australia
- School of Chemistry and Medical Biology, Faculty of Science, Medicine and Health, University of Wollongong, 2500 Wollongong, New South Wales, Australia
| | - Shi Xue Dou
- Institute for Superconducting and Electronic Materials, Australian Institute for Innovative Materials, University of Wollongong, 2500 North Wollongong, New South Wales, Australia
| | - Yusuke Yamauchi
- Australian Institute for Bioengineering and Nanotechnology and School of Chemical Engineering, The University of Queensland, 4702 Brisbane, Queensland, Australia
- JST-ERATO Yamauchi Materials Space-Tectonics Project and International Center for Materials Nanoarchitectonics (WPI-MANA), National Institute for Materials Science (NIMS), 1-1 Namiki, Tsukuba, Ibaraki 305-0044Japan
| | - Konstantin Konstantinov
- Institute for Superconducting and Electronic Materials, Australian Institute for Innovative Materials, University of Wollongong, 2500 North Wollongong, New South Wales, Australia
- Illawarra Health and Medical Research Institute, University of Wollongong, 2500 Wollongong, New South Wales, Australia
| |
Collapse
|